Clinical Impact of the Expanded BioFire Blood Culture Identification 2 Panel in a U.S. Children’s Hospital-Reference-Cited by-同舟云学术

Clinical Impact of the Expanded BioFire Blood Culture Identification 2 Panel in a U.S. Children’s Hospital

Published:2021-09-03 Issue:1 Volume:9 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Graff Kelly E.¹,Palmer Claire¹,Anarestani Toraj²,Velasquez Darcy²,Hamilton Stacey²,Pretty Kristin²,Parker Sarah¹,Dominguez Samuel R.¹²^ORCID

Affiliation:

1. University of Colorado School of Medicine, Department of Pediatrics, Aurora, Colorado, USA

2. Children’s Hospital Colorado, Department of Laboratory and Pathology Medicine, Aurora, Colorado, USA

Abstract

The BioFire BCID2 panel is an accurate panel that is equivalent to the BioFire BCID panel compared to standard culture. The BioFire BCID2 panel offers several advantages over the BioFire BCID panel, including enterococcal species identification, Gram-negative resistance gene detection, Salmonella identification, and the added mecA / mecC and MREJ target for better Staphylococcus aureus and coagulase-negative Staphylococcus (CoNS) differentiation.

Funder

BioFire Diagnostics, LLC

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/Spectrum.00429-21

Reference15 articles.

1. Rapid identification of nonblood sterile site broth cultures using the FilmArray blood culture identification panel

2. Clinical Impact and Provider Acceptability of Real-Time Antimicrobial Stewardship Decision Support for Rapid Diagnostics in Children With Positive Blood Culture Results

3. Randomized Trial of Rapid Multiplex Polymerase Chain Reaction–Based Blood Culture Identification and Susceptibility Testing